Lista de obras - Aaron Polliack - Dominio Público Uruguay

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.

artículo científico publicado en 2015

Absolute lymphocyte count with extreme hyperleukocytosis does not have a prognostic impact in chronic lymphocytic leukemia

artículo científico publicado en 2015

Advising patients on the use of non-herbal nutritional supplements during cancer therapy: a need for doctor-patient communication

artículo científico publicado en 2013

Carbamazepine-induced generalized "pseudoleukemia lymphoma"--like syndrome.

artículo científico publicado en 2003

Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients

artículo científico publicado en 2012

Chronic lymphocytic leukemia: a review of some new aspects of the biology, factors influencing prognosis and therapeutic options

artículo científico publicado en 2005

Coexistence of chronic lymphocytic leukemia and essential thrombocythemia

artículo científico publicado en 2003

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

artículo científico publicado en 2016

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

artículo científico publicado en 2016

Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.

scientific article published on August 2010

Discordant bone marrow involvement in non-Hodgkin lymphoma

artículo científico publicado en 2015

Early interim PET scan in Hodgkin lymphoma: where do we stand?

artículo científico publicado en 2008

Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience

artículo científico publicado en 2015

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

Scientific article published on 3 February 2022

Epidemiology and environmental risk in hairy cell leukemia

artículo científico publicado en 2015

European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.

artículo científico publicado en 2010

Expansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced 'brakes' on host immunity

scientific article published on May 2009

Fatal interstitial pneumonitis related to rituximab-containing regimen

artículo científico publicado en 2006

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL.

artículo científico publicado en 2014

Geography, ethnicity and "roots" in chronic lymphocytic leukemia

artículo científico

Hairy cell leukemia: Uncommon clinical features, unusual sites of involvement and some rare associations

artículo científico publicado en 2015

Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders

artículo científico publicado en 2002

Historical aspects and milestones in the development of effective treatment for hairy cell leukemia

artículo científico publicado en 2009

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia ⬇️

artículo científico publicado en 2015

Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target

artículo científico

Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group

artículo científico publicado en 2012

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

artículo científico publicado en 2017

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

artículo científico publicado en 2013

Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy

artículo científico publicado en 2011

Novel therapeutic options for relapsed hairy cell leukemia

artículo científico publicado en 2015

Ocular adnexal mucosa-associated lymphoid tissue lymphomas: more clues but still a puzzle ⬇️

artículo científico publicado el 7 de octubre de 2010

Optimal management of older patients with chronic lymphocytic leukemia: some facts and principles guiding therapeutic choices

artículo científico

Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases

artículo científico publicado en 2012

Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin

artículo científico publicado en 2012

Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study

artículo científico publicado en 2011

Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.

artículo científico

Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group

artículo científico publicado en 2014

Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.

artículo científico publicado en 2015

Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.

artículo científico publicado en 2003

SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course

artículo científico publicado en 2016

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Scientific article published on 1 March 2022

Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications

artículo científico publicado en 2013

Surface topography of hairy cell leukemia cells compared to other leukemias as seen by scanning electron microscopy

scientific article published on June 2011

T-cell lymphomas in South america and europe

artículo científico publicado en 2012

The late adverse events of rituximab therapy--rare but there!

artículo científico publicado en 2009

Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support.

artículo científico publicado en 2003

Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemia

artículo científico publicado en 2011

Lista de obras de Aaron Polliack

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.

Absolute lymphocyte count with extreme hyperleukocytosis does not have a prognostic impact in chronic lymphocytic leukemia

Advising patients on the use of non-herbal nutritional supplements during cancer therapy: a need for doctor-patient communication

Carbamazepine-induced generalized "pseudoleukemia lymphoma"--like syndrome.

Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients

Chronic lymphocytic leukemia: a review of some new aspects of the biology, factors influencing prognosis and therapeutic options

Coexistence of chronic lymphocytic leukemia and essential thrombocythemia

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches.

Discordant bone marrow involvement in non-Hodgkin lymphoma

Early interim PET scan in Hodgkin lymphoma: where do we stand?

Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience

Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination

Epidemiology and environmental risk in hairy cell leukemia

European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.

Expansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced 'brakes' on host immunity

Fatal interstitial pneumonitis related to rituximab-containing regimen

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL.

Geography, ethnicity and "roots" in chronic lymphocytic leukemia

Hairy cell leukemia: Uncommon clinical features, unusual sites of involvement and some rare associations

Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders

Historical aspects and milestones in the development of effective treatment for hairy cell leukemia

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia ⬇️

Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target

Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy

Novel therapeutic options for relapsed hairy cell leukemia

Ocular adnexal mucosa-associated lymphoid tissue lymphomas: more clues but still a puzzle ⬇️

Optimal management of older patients with chronic lymphocytic leukemia: some facts and principles guiding therapeutic choices

Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases

Predictive parameters for a diagnostic bone marrow biopsy specimen in the work-up of fever of unknown origin

Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study

Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.

Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group

Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.

Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.

SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications

Surface topography of hairy cell leukemia cells compared to other leukemias as seen by scanning electron microscopy

T-cell lymphomas in South america and europe

The late adverse events of rituximab therapy--rare but there!

Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell support.

Unusual clinical manifestations, rare sites of involvement, and the association of other disorders with hairy cell leukemia